These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38785196)

  • 1. Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer.
    Sadat SMA; Vakili MR; Abd-El Hafeez SI; Paladino M; Hall DG; Weinfeld M; Lavasanifar A
    Mol Pharm; 2024 Jul; 21(7):3240-3255. PubMed ID: 38785196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy.
    Sadat SMA; Vakili MR; Paiva IM; Weinfeld M; Lavasanifar A
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33138058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage.
    Sadat SMA; Wuest M; Paiva IM; Munira S; Sarrami N; Sanaee F; Yang X; Paladino M; Binkhathlan Z; Karimi-Busheri F; Martin GR; Jirik FR; Murray D; Gamper AM; Hall DG; Weinfeld M; Lavasanifar A
    Front Oncol; 2021; 11():772920. PubMed ID: 35004293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoencapsulation of Novel Inhibitors of PNKP for Selective Sensitization to Ionizing Radiation and Irinotecan and Induction of Synthetic Lethality.
    Shire Z; Vakili MR; Morgan TDR; Hall DG; Lavasanifar A; Weinfeld M
    Mol Pharm; 2018 Jun; 15(6):2316-2326. PubMed ID: 29688721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3'-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancer.
    Sadat SMA; Paiva IM; Shire Z; Sanaee F; Morgan TDR; Paladino M; Karimi-Busheri F; Mani RS; Martin GR; Jirik FR; Hall DG; Weinfeld M; Lavasanifar A
    J Control Release; 2021 Jun; 334():335-352. PubMed ID: 33933518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis.
    de Paiva IM; Vakili MR; Soleimani AH; Tabatabaei Dakhili SA; Munira S; Paladino M; Martin G; Jirik FR; Hall DG; Weinfeld M; Lavasanifar A
    Mol Pharm; 2022 Jun; 19(6):1825-1838. PubMed ID: 35271294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
    Mahmud A; Xiong XB; Lavasanifar A
    Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the self assembly of methoxy poly(ethylene oxide)-block-poly(α-benzyl carboxylate-ε-caprolactone) for the solubilization and in vivo delivery of valspodar.
    Binkhathlan Z; Elhasi S; Brocks DR; Lavasanifar A
    Curr Drug Deliv; 2012 Mar; 9(2):164-71. PubMed ID: 22283648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
    Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
    Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma.
    Soleimani AH; Garg SM; Paiva IM; Vakili MR; Alshareef A; Huang YH; Molavi O; Lai R; Lavasanifar A
    Drug Deliv Transl Res; 2017 Aug; 7(4):571-581. PubMed ID: 28290050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and Pharmacokinetic Evaluation of Synergistic Fenbendazole and Rapamycin Co-Encapsulated in Methoxy Poly(Ethylene Glycol)-
    Shin HJ; Jo MJ; Jin IS; Park CW; Kim JS; Shin DH
    Int J Nanomedicine; 2021; 16():4873-4889. PubMed ID: 34295160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
    Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
    Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
    Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
    Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
    Shahin M; Ahmed S; Kaur K; Lavasanifar A
    Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin.
    Hassankhani Rad A; Asiaee F; Jafari S; Shayanfar A; Lavasanifar A; Molavi O
    Bioimpacts; 2020; 10(2):87-95. PubMed ID: 32363152
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment.
    Ozawa Y; Kusano K; Owa T; Yokoi A; Asada M; Yoshimatsu K
    Cancer Chemother Pharmacol; 2012 May; 69(5):1353-62. PubMed ID: 22349812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy.
    Li Y; Qu J; Zhang P; Zhang Z
    Nanotechnology; 2020 Nov; 31(45):455101. PubMed ID: 32688350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient-derived xenografts.
    Zhang L; Zhou J; Yan Y; Zhou X; Zhou Q; Du R; Hu S; Ge W; Huang Y; Xu H; Kong Y; Zheng H; Ding Y; Shen Y; Wang W
    Cancer Lett; 2019 Nov; 465():36-44. PubMed ID: 31479691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion.
    Sun X; Zhu D; Cai Y; Shi G; Gao M; Zheng M
    Int J Nanomedicine; 2019; 14():2115-2126. PubMed ID: 30988612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.
    Augustine T; Maitra R; Zhang J; Nayak J; Goel S
    Invest New Drugs; 2019 Oct; 37(5):948-960. PubMed ID: 30612311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.